Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Tissue Cooling System Specifically Designed for Prostate Surgery

By HospiMedica International staff writers
Posted on 03 Dec 2008
A pelvic cooling catheter system has been designed to induce localized cooling during robotic-assisted prostatectomy, the most common surgical technique for prostate cancer. More...


The UroCool catheter system is designed to be placed within the rectal cavity adjacent to the prostate during surgery. The UroCool is used in conjunction with a control console, which circulates cold saline in a closed loop within the catheter to allow for localized cooling. The UroCool catheter system is being developed by InnerCool Therapies, the operating arm of Cardium Therapeutics (San Diego, CA, USA), and is being incorporated into ongoing clinical studies at the University of California Irvine (UCI; USA), which are designed to provide additional information regarding the safety and usefulness of the device pending submission for approval by the U.S. Food and Drug Administration (FDA).

"Our findings using localized cooling techniques during robotic-assisted radical prostatectomy surgery indicate that cooling resulted in a statistically significant faster recovery of urinary continence following surgery,” said Thomas E. Ahlering, M.D., professor and vice chair of the department of urology at UCI. "In addition, based on my surgical experience with therapeutic cooling, I believe that our ongoing studies may offer the potential to demonstrate improved post-operative erectile function for patients as well.”

"InnerCool has now developed a specialized tissue-specific cooling catheter that is being developed to work with InnerCool's current Celsius Control Console which has been marketed and sold since 2003,” added Christopher J. Reinhard, Chairman and CEO of Cardium Therapeutics and InnerCool Therapies. "The new UroCool system may provide an important opportunity to potentially enhance patient recovery of urinary control and erectile function following prostate surgery. These side effects of prostate surgery are serious, profound and frequent, and all too often patients defer proper surgical treatment because of these quality-of-life issues, underscoring the importance of new therapeutic approaches.”

Related Links:
Cardium Therapeutics
University of California Irvine


Gold Member
12-Channel ECG
CM1200B
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Mammography System (Analog)
MAM VENUS
Hemostatic Agent
HEMOBLAST Bellows
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.